- Home
- CNM vs SNN Comparison
CNM vs SNN Comparison
Compare CNM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNM | SNN |
|---|---|---|
| Founded | 1996 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Durable Goods | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 14.0B |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | CNM | SNN |
|---|---|---|
| Price | $50.26 | $33.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | ★ $60.00 | $32.83 |
| AVG Volume (30 Days) | ★ 2.5M | 476.9K |
| Earning Date | 12-09-2025 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | 7.24 | ★ 59.91 |
| EPS | ★ 2.25 | 0.56 |
| Revenue | ★ $7,740,000,000.00 | $5,944,000,000.00 |
| Revenue This Year | $4.45 | $7.78 |
| Revenue Next Year | $4.43 | $5.13 |
| P/E Ratio | ★ $22.35 | $29.10 |
| Revenue Growth | ★ 11.02 | 5.35 |
| 52 Week Low | $43.18 | $23.69 |
| 52 Week High | $67.18 | $38.79 |
Technical Indicators
Market Signals| Indicator | CNM | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 55.83 | 48.01 |
| Support Level | $44.59 | $32.68 |
| Resistance Level | $50.10 | $33.56 |
| Average True Range (ATR) | 1.61 | 0.41 |
| MACD | 0.65 | 0.14 |
| Stochastic Oscillator | 93.62 | 78.51 |
Price Performance
Historical ComparisonAbout CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.